AI Treatment Analysis
Powered by Agilisium Context AI — Precision Medicine Engine
FDA Black Box Warning — Clopidogrel (Plavix)
FDA VerifiedWARNING: DIMINISHED ANTIPLATELET EFFECT IN PATIENTS WITH TWO LOSS-OF-FUNCTION ALLELES OF THE CYP2C19 GENE. The effectiveness of Plavix is dependent on its activation to an active metabolite by the cytochrome P450 (CYP) system, principally CYP2C19. Tests are available to identify patients who are CYP2C19 poor metabolizers. Consider use of another platelet P2Y12 inhibitor in patients identified as CYP2C19 poor metabolizers.
Source: OpenFDA Drug Label API — GET /drug/label.json?search=openfda.generic_name:"clopidogrel"
Select Patient
Selected Patient
Rajesh Kumar
58y · Male · B+
ID: PAT-DEMO001
Conditions
Type 2 Diabetes, Hypertension, Coronary Artery Disease
Medications
4 active
Allergies
Penicillin, Sulfonamides
Genomic Variants
3 flagged
Laboratory Results
Metabolic Panel
Lipid Panel
Analysis Parameters
Powered by GPT-4o · Agilisium Context AI
Verified Data Sources